This program brings data, experience, and differing viewpoints into open conversation so clinicians can work through the real decisions behind treatment choices. Debates, Q and A, and case discussion create a space where evidence is challenged and clarified, making the takeaways immediately useful in practice.

Explore the comparison below to understand what makes LL&M Great Debates a uniquely valuable forum for clinical decision making.

Key Features

LL&M Great Debates

Compared to Other Hematology Meetings

Scope of Curriculum Covers the full spectrum of hematologic malignancies (leukemia, lymphoma, myeloma, and CLL) with expert discussions on frontline and relapsed/refractory settings, sequencing, novel agents, and precision medicine. Typically narrower in scope or disease-specific, with limited cross-category insight.
Learning Format Built on point–counterpoint debate, panel dialogue, and open Q&A that place attendees in the conversation. Evidence is examined in real time to clarify clinical decisions, and attendees cast votes before and after the discussions that reveal how each debate shifts perspectives in the room. Commonly lecture-driven with minimal exchange or audience participation.
Integration with LL&M Congress Anchored within the broader LL&M educational ecosystem, offering continuity across the annual Congress, Winter Symposium, and APP Institute to extend learning beyond this meeting. Most meetings operate independently without year-round connection to related programs.
Community & Continuity A longstanding, interactive community that values open debate and shared experience to refine patient care across the hematology spectrum, with each meeting bringing a balanced mix of returning and new faculty. Many conferences function as isolated updates rather than ongoing collaborative forums.
Back to top